Cerebrolysin vs Selank
Updated 7 sources
Key differences
- 1Cerebrolysin is a course-based neurotrophic drug for stroke, TBI and dementia; Selank is a calming-focused short peptide.
Side by side
Facts from each record, in the same words as their own pages.
| Cerebrolysin | Selank | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Forms |
|
|
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
7 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.
Regulatory5
- Cerebrolysin parenterale Lösung, Fachinformation (SmPC), March 2021BASG (Austria) · checked Oct 24, 2026
- Selank 0.15% nasal drops (Russian label)Vidal, via a reference work · checked Oct 24, 2026
- Selank instruction for use (Russian label)selank.ru (Peptogen), archived copy, via a vendor guide · checked Oct 24, 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (updated May 14, 2026)FDA · checked Oct 24, 2026
Reference work1
- CerebrolysinWikipedia · checked Oct 24, 2026
Competitor guide1
- Cerebrolysin protocol guidepeptidedosingprotocols.com · checked Oct 24, 2026